leading glp-1 treatments for diabetes 2025 Pharma Giants Bet on Next-Generation to Sustain Growth Top Obesity and Diabetes Medications

Most insurance plans cover GLP-1s when they are used to treat diabetes, but coverage of the weight loss drugs is less widespread

In addition, the GLP-1 drug semaglutide (branded as Ozempic, Wegovy, and Rybelsus) was selected for Medicare drug price negotiation in 2025, with a negotiated price set to take effect in 2027

For women considering tirzepatide specifically for PCOS, the effects of tirzepatide on menstrual cycles deserve careful attention

Pharm World Sci

While compounded medications use active ingredients sourced from FDA-registered facilities under the direction of prescribing clinicians, the finished compounded products themselves have not undergone FDA review as complete formulations

A 2003 law currently prohibits Medicare from covering drugs for weight loss alone